Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Effects of Nimodipine in Patients With Schizophrenia

NCT03671525 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03671525
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03671525 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Effects of Nimodipine in Patients With Schizophrenia
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Completed
Start date
October 5, 2018
Completion date
May 12, 2023
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

schizo affective disorder, schizophrenia